Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)
- PMID: 22427130
- DOI: 10.1007/s10620-012-2112-9
Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)
Abstract
Background: A role of an altered dietary pattern (e.g., a diet rich in sugar) but also alterations at the level of the intestinal barrier have repeatedly been discussed to be involved in the development and progression of nonalcoholic fatty liver disease (NAFLD).
Aims: To determine if the nutritional intake, intestinal flora, and permeability and the development of NAFLD are related in humans.
Methods: Ten controls and 20 patients with NAFLD ranging from simple steatosis to steatohepatitis were included in the study. Bacterial overgrowth, orocecal transit time, and intestinal permeability were assessed. Alcohol, endotoxin, and plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma. Nutritional intake was assessed using a dietary history.
Results: Despite no differences in the prevalence of bacterial overgrowth and in the orocecal transit time, intestinal permeability, alcohol, and endotoxin levels in plasma were significantly higher in patients with NAFLD than in controls. Similar results were also found for PAI-1 plasma concentrations. Patients with NAFLD had a significantly higher intake of protein, total carbohydrates, and mono- as well as disaccharides than controls. PAI-1, endotoxin, and ALT plasma levels were positively related to total protein and carbohydrate intake.
Conclusions: Taken together, our results indicate that intestinal permeability, endogenous alcohol synthesis, and nutritional intake are markedly altered in patients with NAFLD.
Similar articles
-
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.J Nutr. 2008 Aug;138(8):1452-5. doi: 10.1093/jn/138.8.1452. J Nutr. 2008. PMID: 18641190
-
A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.Eur J Nutr. 2013 Mar;52(2):527-35. doi: 10.1007/s00394-012-0355-z. Epub 2012 Apr 28. Eur J Nutr. 2013. PMID: 22543623
-
Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.Nutrients. 2018 Sep 19;10(9):1329. doi: 10.3390/nu10091329. Nutrients. 2018. PMID: 30235828 Free PMC article.
-
Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2023 Oct;21(11):2746-2758. doi: 10.1016/j.cgh.2022.11.030. Epub 2022 Dec 5. Clin Gastroenterol Hepatol. 2023. PMID: 36470528 Review.
-
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377. World J Gastroenterol. 2011. PMID: 21876630 Free PMC article. Review.
Cited by
-
In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease.Probiotics Antimicrob Proteins. 2024 Feb 6. doi: 10.1007/s12602-024-10219-1. Online ahead of print. Probiotics Antimicrob Proteins. 2024. PMID: 38319537
-
Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis.NPJ Biofilms Microbiomes. 2024 Jan 17;10(1):3. doi: 10.1038/s41522-024-00476-x. NPJ Biofilms Microbiomes. 2024. PMID: 38233485 Free PMC article.
-
Utility of ultrasonography in a mouse model of non-alcoholic steatohepatitis induced by a choline-deficient, high-fat diet and dextran sulfate sodium.Biochem Biophys Rep. 2023 Nov 8;36:101575. doi: 10.1016/j.bbrep.2023.101575. eCollection 2023 Dec. Biochem Biophys Rep. 2023. PMID: 38115886 Free PMC article.
-
Histone Modifications in NAFLD: Mechanisms and Potential Therapy.Int J Mol Sci. 2023 Sep 27;24(19):14653. doi: 10.3390/ijms241914653. Int J Mol Sci. 2023. PMID: 37834101 Free PMC article. Review.
-
Human α-Defensin 51-9 and Human β-Defensin 2 Improve Metabolic Parameters and Gut Barrier Function in Mice Fed a Western-Style Diet.Int J Mol Sci. 2023 Sep 9;24(18):13878. doi: 10.3390/ijms241813878. Int J Mol Sci. 2023. PMID: 37762180 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
